Autoimmunity in primary immune deficiency: taking lessons from our patients (Q33394794)

26 July 2017

1 reference

title

Autoimmunity in primary immune deficiency: taking lessons from our patients (English)

1 reference

Charlotte Cunningham-Rundles

26 July 2017

author

series ordinal

1

object named as

C Cunningham-Rundles

1 reference

26 July 2017

publication date

1 June 2011

1 reference

Clinical and Experimental Immunology

26 July 2017

published in

1 reference

26 July 2017

volume

164 Suppl 2

1 reference

26 July 2017

page(s)

6-11

1 reference

AIRE in the thymus and beyond

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

B-cell tolerance checkpoints in health and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Significance of the Simultaneous Occurrence of Connective Tissue Disease and Agammaglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Bruton's tyrosine kinase is essential for human B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Autoimmune manifestations in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Autoimmunity in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Memory B cells in common variable immunodeficiency: clinical associations and sex differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

The EUROclass trial: defining subgroups in common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

TACI is mutant in common variable immunodeficiency and IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

The BAFF/APRIL system: an important player in systemic rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

Clinical spectrum of X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04388.X

The role of TALL-1 and APRIL in immune regulation

21 January 2018

1 reference

12 December 2020

Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease

1 reference

12 December 2020

Common variable immunodeficiency

1 reference

12 December 2020

Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes

1 reference

12 December 2020

Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo

1 reference

12 December 2020

10.1111/J.1365-2249.2011.04388.X

Identifiers

DOI

1 reference

26 July 2017

0 references

1 reference